(Source: sbrihealthcare.co.uk)
SBRI Healthcare has awarded a total of £3.8m in funding to four innovative technology companies that are in the process of developing cutting edge cancer diagnostic tools.
The companies, C the Signs, Cambridge Oncometrix, Chromition and Deep Med IO were among the winners of the July 2017 SBRI Healthcare national competition, which had appealed for healthcare technology solutions geared specifically towards more effective cancer screening and diagnosis. Today’s phase two funding comes in addition to the original £100k investment award made by SBRI Healthcare to each of these companies.
Now that these winning companies have demonstrated technical feasibility over a six-month development phase, the latest investment by SBRI Healthcare means that the companies are in a position to further develop and commercialise their technologies, and be fast-tracked to market. C the Signs is already available on the NHS and the other innovations could potentially be used in primary care or within NHS hospitals in the next few years.
